1984
DOI: 10.1007/bf00517307
|View full text |Cite
|
Sign up to set email alerts
|

In vivo release by histamine agonists and antagonists of endogenous catecholamines in the cat hypothalamus

Abstract: The posterior hypothalamus of anaesthetized cats was superfused through a push-pull cannula with histamine agonists and antagonists and the release of endogenous catecholamines was determined in the superfusate. Hypothalamic superfusion with histamine, 2-methylhistamine (H1-agonist), dimaprit (H2-agonist) or metiamide (H2-antagonist) enhanced the release of the catecholamines dopamine, noradrenaline and adrenaline. The releasing effects of these substances depended on the presence of calcium ions. Superfusion … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
14
0

Year Published

1986
1986
2006
2006

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(14 citation statements)
references
References 24 publications
0
14
0
Order By: Relevance
“…Levels rose early in the light phase and were highest during illumination for levels of norepinephrine [55,56], gammaaminobutyric acid [57], cortisol [58,59], vasopressin [60] and oxytocin [60][61][62]. Although no causal relationship has been demonstrated to link these rhythmic changes in monkey CSF, it is interesting to note that histamine and histamine agonists were shown to stimulate in vivo release of catecholamines in the hypothalamus of the cat [63] and peptide hormones in rodents and man [see 8].…”
Section: Discussionmentioning
confidence: 97%
“…Levels rose early in the light phase and were highest during illumination for levels of norepinephrine [55,56], gammaaminobutyric acid [57], cortisol [58,59], vasopressin [60] and oxytocin [60][61][62]. Although no causal relationship has been demonstrated to link these rhythmic changes in monkey CSF, it is interesting to note that histamine and histamine agonists were shown to stimulate in vivo release of catecholamines in the hypothalamus of the cat [63] and peptide hormones in rodents and man [see 8].…”
Section: Discussionmentioning
confidence: 97%
“…These data implied a possibility that a putative histamine transporter would have a similar structure to other monoamine transporters. Accordingly, we investigated the effects of monoamine uptake inhibitors on [ [1,6,25,41,46] , and also has many interactions with other neurotransmitters [22] . Histamine agonists and antagonists modulate dopamine release and dopamine turnover via histamine H 3 receptors and dopamine agonists, and antagonists modulate histamine release via dopamine receptors in the hypothalamus [3,4,22,24,27,37,38] .…”
Section: Discussionmentioning
confidence: 99%
“…The possibility that the inhibitory effect of RmHA is mediated via H3 heteroreceptors located on serotonergic or adren ergic neurons would seem to be in accordance with the fact that serotonin exerts stimulatory and norepinephrine exerts both inhibitory and stimulatory actions on the re lease of PRL, ACTH and (TEND [29][30][31], Inhibition of serotonin and norepinephrine release by RmHA-or HAinduced activation of Hi heteroreceptors might therefore lead to a decreased hormone response to stress. However, interpretation of the data is intricate, since it has also been found that HA stimulates hypothalamic norepi nephrine release by activation of Hi or Hj receptors [32,33] and that HA increases synaptosomal release of sero tonin [34] and its turnover in the hypothalamus probably by activation of H: receptors [35]. Furthermore, hista minergic stimulation of PRL secretion seems to involve serotonergic neurons [36], Blockade of Hi receptors by the antagonist thiopera mide prevented the inhibitory effect of the H?…”
Section: Discussionmentioning
confidence: 99%